D. E. Shaw & Co., Inc. - AXOVANT SCIENCES LTD ownership

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of AXOVANT SCIENCES LTD
ValueSharesWeighting
Q4 2017$381,000
-25.7%
72,379
-3.0%
0.00%0.0%
Q3 2017$513,000
-98.7%
74,591
-95.6%
0.00%
-98.5%
Q2 2017$39,129,000
+71.0%
1,687,335
+10.1%
0.06%
+62.5%
Q1 2017$22,889,000
+20.8%
1,532,060
+0.5%
0.04%
+25.0%
Q4 2016$18,942,000
-12.2%
1,525,132
-1.1%
0.03%
-15.8%
Q3 2016$21,584,000
+9.6%
1,541,687
+0.5%
0.04%
+5.6%
Q2 2016$19,695,000
+13.5%
1,533,886
+1.5%
0.04%
+16.1%
Q1 2016$17,353,000
-40.2%
1,511,514
-6.1%
0.03%
-27.9%
Q4 2015$29,030,000
+14.4%
1,610,092
-18.0%
0.04%
+16.2%
Q3 2015$25,380,000
-28.8%
1,964,397
+12.3%
0.04%
-30.2%
Q2 2015$35,665,0001,750,0000.05%
Other shareholders
AXOVANT SCIENCES LTD shareholders Q3 2023
NameSharesValueWeighting ↓
RA Capital Management 5,000,000$57,400,0007.34%
VHCP Management II, LLC 429,590$4,932,0003.24%
VHCP Management, LLC 184,110$2,114,0001.84%
Visium Asset Management, LP 4,192,769$48,132,0000.82%
Perceptive Advisors 485,000$5,568,0000.49%
Opus Point Partners Management, LLC 26,416$303,0000.23%
Virtus ETF Advisers LLC 12,579$144,0000.20%
BOURGEON CAPITAL MANAGEMENT LLC 20,700$238,0000.16%
AMERICAN FINANCIAL GROUP INC 172,395$1,980,0000.15%
NJ State Employees Deferred Compensation Plan 51,000$640,0000.14%
View complete list of AXOVANT SCIENCES LTD shareholders